BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

333 related articles for article (PubMed ID: 31840555)

  • 1. IgA nephropathy suspected to be combined with Fabry disease or Alport syndrome: a case report.
    Hao W; Ao L; Zhang C; Zhu L; Xie D
    J Int Med Res; 2020 Mar; 48(3):300060519891290. PubMed ID: 31840555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Alport syndrome misdiagnosed with IgA nephropathy from familial history: a case report and brief review.
    Rahimzadeh H; Ajlou S; Nili F; Razeghi E
    BMC Nephrol; 2023 Apr; 24(1):97. PubMed ID: 37059980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tale of two nephropathies; co-occurring Alport syndrome and IgA nephropathy, a case report.
    Bhattacharyya A; Huang Y; Khan SH; Drachenberg CB; Malone LC
    BMC Nephrol; 2021 Oct; 22(1):358. PubMed ID: 34717572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hemizygous Fabry disease associated with IgA nephropathy: a case report.
    Shimohata H; Yoh K; Takada K; Tanaka H; Usui J; Hirayama K; Kobayashi M; Yamagata K
    J Nephrol; 2009; 22(5):682-4. PubMed ID: 19810002
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and pathological characteristics of Fabry disease combined with IgA nephropathy in Chinese patients
.
    Yang N; Wang X; Xu F; Zeng C; Wang J; Liu Z
    Clin Nephrol; 2017 Apr; 87 (2017)(4):188-195. PubMed ID: 28157068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coexistence of Fabry disease and IgA nephropathy: a report of two cases.
    Yin G; Wu Y; Zeng CH; Chen HP; Liu ZH
    Ir J Med Sci; 2014 Dec; 183(4):671-5. PubMed ID: 24913738
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thin basement membrane nephropathy.
    Savige J; Rana K; Tonna S; Buzza M; Dagher H; Wang YY
    Kidney Int; 2003 Oct; 64(4):1169-78. PubMed ID: 12969134
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Genetic variants of familial hematuria associated genes in three families with hematuria with probands initially diagnosed as IgA nephropathy].
    Liu JW; Wang P; Huang J; Nie XJ; Zhao F; Chen LZ; Li Z; Yu ZH
    Zhonghua Er Ke Za Zhi; 2019 Sep; 57(9):674-679. PubMed ID: 31530352
    [No Abstract]   [Full Text] [Related]  

  • 9. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
    Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
    G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The coincidence of IgA nephropathy and Fabry disease.
    Maixnerová D; Tesař V; Ryšavá R; Reiterová J; Poupětová H; Dvořáková L; Goláň L; Neprašová M; Kidorová J; Merta M; Honsová E
    BMC Nephrol; 2013 Jan; 14():6. PubMed ID: 23305247
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pediatric glomerular hematuria: a clinicopathological study.
    Moustafa FE; Eid R; Hamdy N
    Clin Exp Nephrol; 2020 Jul; 24(7):613-621. PubMed ID: 32198715
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A unique evolution of the kidney phenotype in a patient with autosomal recessive Alport syndrome.
    Vischini G; Kapp ME; Wheeler FC; Hopp L; Fogo AB
    Hum Pathol; 2018 Nov; 81():229-234. PubMed ID: 29530752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinicopathological study of patients presenting hematuria and proteinuria by renal biopsy].
    Shinohara Y; Mitsui H; Nasu T; Hayashida S
    Nihon Hinyokika Gakkai Zasshi; 1991 Jan; 82(1):72-9. PubMed ID: 2046202
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of anti-glomerular basement membrane glomerulonephritis during the course of IgA nephropathy: a case report.
    Kojima T; Hirose G; Komatsu S; Oshima T; Sugisaki K; Tomiyasu T; Yoshikawa N; Yamada M; Oda T
    BMC Nephrol; 2019 Jan; 20(1):25. PubMed ID: 30683055
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hematuria and risk for end-stage kidney disease.
    Vivante A; Calderon-Margalit R; Skorecki K
    Curr Opin Nephrol Hypertens; 2013 May; 22(3):325-30. PubMed ID: 23449218
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Autosomal dominant form of type IV collagen nephropathy exists among patients with hereditary nephritis difficult to diagnose clinicopathologically.
    Imafuku A; Nozu K; Sawa N; Hasegawa E; Hiramatsu R; Kawada M; Hoshino J; Tanaka K; Ishii Y; Takaichi K; Fujii T; Ohashi K; Iijima K; Ubara Y
    Nephrology (Carlton); 2018 Oct; 23(10):940-947. PubMed ID: 28704582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel
    Chen YT; Jiang WZ; Lu KD
    World J Clin Cases; 2023 Sep; 11(25):5947-5953. PubMed ID: 37727481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fabry-like laminated myelin body associated with IgA nephropathy.
    Yoshida A; Morozumi K; Takeda A; Koyama K; Oikawa T
    Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1303-7. PubMed ID: 7853764
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study of asymptomatic microscopic hematuria in potential living related kidney donors.
    Sobh MA; Moustafa FE; el-Din Saleh MA; Tawfik A; Ghoneim MA
    Nephron; 1993; 65(2):190-5. PubMed ID: 8247179
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hemizygous Fabry disease associated with membranous nephropathy: A rare case report
.
    Zhou W; Ni Z; Zhang M
    Clin Nephrol; 2018 Sep; 90(3):227-231. PubMed ID: 29792392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.